N-[7-(7-Chloro-quinolin-4-ylamino)-heptyl]-2,3-dihydroxy-succinamic acid | 752209-74-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-[7-(7-Chloro-quinolin-4-ylamino)-heptyl]-2,3-dihydroxy-succinamic acid
• CAS: 752209-74-8
• 化学式: C₂₀H₂₆ClN₃O₅
• 分子量: 423.897
• InChiKey: FMRWBJVQSJYZBG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.17
• 重原子数：
  29.0
• 可旋转键数：
  12.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  131.78
• 氢给体数：
  5.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  N-[7-(7-Chloro-quinolin-4-ylamino)-heptyl]-2,3-dihydroxy-succinamic acid 在 sodium periodate 作用下， 以 phosphate buffer 为溶剂， 生成 N-[7-(7-Chloro-quinolin-4-ylamino)-heptyl]-2-oxo-acetamide
  参考文献：
  名称：

  Design, synthesis and antimalarial activity of a glyoxylylhydrazone library

  摘要：

  Synthesis of a new family of quinolylhydrazone derivatives and evaluation of their activity against a chloroquine-resistant strain of Plasmodium falciparum are described. The best compound displayed an activity 6-fold higher than chloroquine. None of the active compounds were found to inhibit beta-hematin formation in vitro in the same range as chloroquine and five among them displayed lower calculated vacuolar accumulation ratios, suggesting the implication of a different mechanism of action. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.06.056
• 作为产物：
  描述：

  1,7-二氨基庚烷 在 碳酸氢钠 作用下， 以 四氢呋喃 、 戊醇 为溶剂， 反应 16.0h， 生成 N-[7-(7-Chloro-quinolin-4-ylamino)-heptyl]-2,3-dihydroxy-succinamic acid
  参考文献：
  名称：

  Design, synthesis and antimalarial activity of a glyoxylylhydrazone library

  摘要：

  Synthesis of a new family of quinolylhydrazone derivatives and evaluation of their activity against a chloroquine-resistant strain of Plasmodium falciparum are described. The best compound displayed an activity 6-fold higher than chloroquine. None of the active compounds were found to inhibit beta-hematin formation in vitro in the same range as chloroquine and five among them displayed lower calculated vacuolar accumulation ratios, suggesting the implication of a different mechanism of action. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.06.056